Moderna’s Partnership Will Build On A New And Unproven Vaccine Approach
William Schief, an immunology professor at Scripps Research and vaccine design director of the International AIDS Vaccine Initiative, presented Moderna’s investors with unpublished data from an HIV vaccine trial presented at a virtual AIDS research conference in February.
The trial, which started in 2018, was conducted with 48 HIV-negative adults, and will serve as preliminary basis off which Moderna and its collaborators will further study and test a vaccine approach targeting broadly neutralizing antibodies. Subjects were given either a low or high dose of the protein-based vaccine candidate, which was designed to activate certain “naive” B cells of the immune system.
When activated, the B cells produce proteins that eventually give rise to the hoped-for broadly neutralizing antibodies.
“The importance of priming these naive B cells is the key first step,” Schief said on the investor call. “If you can’t get that to work, the whole thing isn’t going to work.”
After being treated with the experimental vaccine, 47 out of 48 participants showed the targeted levels of naive B cells critical in eventually producing the antibodies, though the data remains subject to peer review. The final study volunteer dropped out.
Moderna’s cost and time-efficient mRNA technology will speed up the process of conducting clinical trials, Schief said. Relatively speaking, conventional in-lab protein manufacturing is slow and expensive.
Approaches To Destroying Or Damaging The Virion Or Its Parts
Here, âdamageâ means inhibiting or stopping the ability of virion to process any of the Phase II-VII. Here are the different classification of methods:
So Why Is That So Hard To Do With Hiv
First of all, said Jefferys, lack of interest and funding are no longer really among the reasons. There was a period in the early 1990s when you could argue that HIV vaccine research was underfunded, he said. But by now, its a substantial budget. According to an analysis by the Resource Tracking for HIV Prevention Research & Development Working Group, a project of the HIV vaccine advocacy group AVAC, nearly $15.3 billion was spent on HIV vaccine research between 2000 and 2019. The money comes from philanthropic, public, and private groups like the Bill & Melinda Gates Foundation.
And if that money hasnt led yet to an effective vaccine, it has led to an enormous amount of information about both HIV and the immune system that led, in part, to the rapid development of COVID vaccines. HIV research helped reveal the importance of creating a vaccine using modified forms of invaders outer spike proteins to generate immune responses. HIV vaccine research also led to the perfection of mRNA as a vaccine method conceptused successfully for COVID, not so much for HIV.
Why the disparity? The short answer is that HIV is one of the wiliest, most slippery viruses known to modern science. And that answer breaks down into many factors.
Read Also: Is Undetectable Hiv Contagious
Myth: Hiv Vaccines Can Give People Hiv
Fact: This statement is false: a person CANNOT get HIV from the study HIV vaccines because these study vaccines do not contain real HIV . Some vaccines, like those for typhoid or polio, may contain a weak form of the virus they are protecting against, but this is not the case for HIV vaccines. Scientists make HIV vaccines so that they look like the real virus, but they do not contain any HIV. Think of it like a photocopy: it might look similar, but it isn’t the original. In the past 25 years more than 30,000 volunteers have taken part in HIV vaccine studies worldwide, and no one has been infected with HIV by any of the study vaccines tested because they do not contain HIV.
Is There A Cure For Hiv And Aids
There is no cure for HIV, although antiretroviral treatment can control the virus, meaning that people with HIV can live long and healthy lives.
Most research is looking for a functional cure where HIV is permanently reduced to undetectable and harmless levels in the body, but some residual virus may remain.
Other research is looking for a sterilising cure where HIV is removed from the body completely, but this is more complicated and risky.
Trials of HIV vaccines are encouraging, but so far only offer partial protection.
There is no cure for HIV yet. However, antiretroviral treatment can control HIV and allow people to live a long and healthy life.
For some people, treatment can reduce the level of HIV in their body to such a low amount that they are unable to pass it on . Having an undetectable viral load can keep you healthy, but its not a cure for HIV. To maintain an undetectable viral load a person must keep adhering to their antiretroviral treatment.
You May Like: Can You Get Hiv From Dried Blood
Myth: Vaccines Cause Autism And Just Arent Safe
Fact: This is false. Many studies have found this claim to be false. The British doctor who originally published the finding about vaccines and autism has since been found to have falsified his data, and was stripped of his license to practice medicine. There is no link between childhood vaccination and autism. It is true that vaccines often have side effects, but those are typically temporary and go away after a day or two. The value of protection to vaccinated individuals and to the public has made vaccines one of the top public health measures in history, second only to having a clean water supply.
Why Theres No Hiv Cure Yet
Over the past two years, the phrase HIV cure has flashed repeatedly across newspaper headlines. In March 2013, doctors from Mississippi reported that the disease had vanished in a toddler who was infected at birth. Four months later, researchers in Boston reported a similar finding in two previously HIV-positive men. All three were no longer required to take any drug treatments. The media heralded the breakthrough, and there was anxious optimism among HIV researchers. Millions of dollars of grant funds were earmarked to bring this work to more patients.
But in December 2013, the optimism evaporated. HIV had returned in both of the Boston men. Then, just this summer, researchers announced the same grim results for the child from Mississippi. The inevitable questions mounted from the baffled public. Will there ever be a cure for this disease? As a scientist researching HIV/AIDS, I can tell you theres no straightforward answer. HIV is a notoriously tricky virus, one thats eluded promising treatments before. But perhaps just as problematic is the word cure itself.
The progression from HIV infection to AIDS and eventual death occurs in over 99% of untreated casesmaking it more deadly than Ebola or the plague. Despite being identified only a few decades ago, AIDS has already killed 25 million people and currently infects another 35 million, and the World Health Organization lists it as the sixth leading cause of death worldwide.
Recommended Reading: Can You Get Hiv From Dried Blood
Why Isn’t There A Vaccine For The Common Cold
Sanja Jelic, MD is board-certified in pulmonary disease, sleep medicine, critical care medicine, and internal medicine. She is an assistant professor and attending physician at Columbia University College of Physicians and Surgeons in New York, NY.
Vaccines are an important public health strategy to better protect people from viruses like measles and influenza. Despite efforts to produce a vaccine for the common cold, no such product has yet been developed.
Scientists have been trying to develop a cold vaccine without success since the 1950s. This is due in part to the fact that colds aren’t caused by a single virus. However, new technologies may soon overcome this challenge and bring the promise of a cold vaccine closer to reality.
Moderna Is About To Begin Trials For Hiv Vaccine Based On Covid
Moderna, the biotech company that developed one of the first COVID-19 vaccines last year, is hoping to break new ground this week in fighting another pandemic: HIV/AIDS.
The company will soon begin human trials for their mRNA-based vaccine, according to information posted to the National Institute of Healths clinical trials database last week. Moderna is seeking 56 individuals, aged 18 to 50 and who are HIV-negative, for the trial, which is estimated to begin on August 19 and conclude in spring 2023. Moderna is also reportedly developing an influenza vaccine based on the same technology.
Modernas vaccines passed Phase I testing earlier this year, which involves testing for safety using only a handful of human volunteers. Phase II tests for a vaccines overall effectiveness, and with the move into Phase III, Moderna will be looking at its efficacy versus other prevention treatments currently on the market, such as pre-exposure prophylaxis, also known as PreP.
Since the late 1700s, researchers have developed several different types of vaccines, but most vaccines for other viruses have proven ineffective against HIV. Also known as the human immunodeficiency virus, it attacks the immune system itself and breaks down the bodys ability to fight other diseases and infections.
If new vaccine-resistant forms of HIV arise, researchers would be able to edit the mRNA to produce slightly different proteins with far less genetic material than other types of vaccines.
Read Also: What Is The Average Life Expectancy Of Hiv Patients
Two Sexes Are Not Enough
In the three decades since, over 25 more highly-potent drugs have been developed and FDA-approved to treat HIV. When two to five of them are combined into a drug cocktail, the mixture can shut down the viruss replication, prevent the onset of AIDS, and return life expectancy to a normal level. However, patients must continue taking these treatments for their entire lives. Though better than the alternative, drug regimens are still inconvenient and expensive, especially for patients living in the developing world.
Given modern medicines success in curing other diseases, what makes HIV different? By definition, an infection is cured if treatment can be stopped without the risk of it resurfacing. When you take a week-long course of antibiotics for strep throat, for example, you can rest assured that the infection is on track to be cleared out of your body. But not with HIV.
Myth: A Person Must Be Hiv
Fact: This is false. The vaccines being tested by the HVTN are preventive vaccines. They must be tested on volunteers who are not infected with HIV, because our goal is to keep people that way. There are other research groups that are conducting studies of therapeutic vaccines that might be used in people who are already infected with HIV.
You May Like: Does Cookie Johnson Have Aids
What Should I Do Until Theres A Cure For Hiv
For now, the best thing to do for your health is to test regularly for HIV. Testing is the only way to know for sure if you have the virus.
If youve already tested and your result is positive, youll be advised to start antiretroviral treatment as soon as possible. Treatment is the only way to manage HIV and prevent it from damaging your immune system. It also reduces the risk of passing HIV on to your sexual partners. With treatment, people living with HIV can have long and healthy lives.
However No One Has Yet Been Able To Induce These Antibodies Outside Of The Handful Of Individuals Who Can Produce Them On Their Own
The three new scientific papers suggest that it might be possible to reverse-engineer the way immune cells make BNABs.
One team of researchers constructed a very close mimic of the three-pronged structure on HIV that allows the virus to latch on to human cells. Because this structure is a crucial part of how the virus attacks and because this component has some of the few patches of DNA that do not change across the many million different strains of HIV it’s a good target for an antibody.
“HIV is a crafty virus we’ve learned that the hard way over the years,” Koff said. “But this is its achilles heel.”
With this model of the structure now in hand, the researchers hope to figure out a way to induce an antibody called VRC01, one of the BNABs originally found in Donor 45, that binds to it and prevents it from infecting human cells.
“If we can’t do that, we’re pretty unlikely to make a vaccine,” Schief said.
The two other papers showed that although immune cells in mice can make a close cousin of the VRC01 antibody, it can only bind to a small number of HIV strains. The antibody would need to undergo many more mutations brought on by further immunizations within the cell before it can consistently bind to a large enough number of HIV strains.
This would likely require multiple immunizations, each causing the antibody to further mutate until its targets are sufficiently broad. While the first step is clear, the following steps are still unknown.
Also Check: How Long Does It Take For Hiv To Become Aids
Is An Hiv Vaccine On The Way
- HIV vaccine science has taught researchers a lot about the human immune system.
- Testing has occurred for two kinds of HIV vaccines those that prevent HIV and those that treat HIV.
- HIV vaccine trials are promising, but no vaccines have been approved yet.
When the human immunodeficiency virus was first discovered in 1984, researchers vowed to find a cure. But what they had yet to discover was that HIV is a complex virus. Much more had to be learned about the human immune system and the virus itself before a vaccine could be made.
Now, almost 40 years later, weve made significant advancements in how the infection is treated, but researchers have yet to develop an HIV vaccine. And although new HIV cases have gone down significantly since the mid-1980s, it remains a major public health concern, and a vaccine is still needed.
Here well discuss the latest research on and pipeline for an HIV vaccine, and if we can expect one to be available soon.
What Is The Difference Between Pre
People can take medications to lower their risk of infection before coming into contact with HIV. This method of preventing HIV is known as pre-exposure prophylaxis or PrEP.
An HIV vaccine would also prevent someone from getting HIV if exposed, but would likely make a much larger impact on the HIV epidemic overall than PrEP alone.
Even though some of the medications used for PrEP are also used to treat HIV, they are used differently for each indication. PrEP is used before a possible exposure by someone who might be at risk of contracting the virus. HIV treatment, on the other hand, includes a combination of medications to lower the amount of virus in the body in someone who already has HIV.
Next well talk about PrEP and how it differs from an HIV vaccine.
You May Like: Does Hiv Cause Hair Loss
Some Lgbtq+ People Worry That The Covid
Originally published by The 19th
Thirty-two percent of LGBTQ+ adults say they are worried that getting vaccinated against COVID-19 could negatively affect their medication for treating or preventing HIV, according to a survey and a California-based market research firm. The HRC did not poll to determine what percentage of those concerned adults had actually had the shot.Experts told The 19th that there is no evidence the two treatments interact negatively.
This worry among people living with HIV/AIDs is very concerning, experts say especially among Black and Latinx LGBTQ+ people, who are disproportionately affected by HIV and who the HRC found to be more worried about COVID vaccination impacting their HIV treatment. Among Black LGBTQ+ people surveyed in the online July poll, 39 percent were worried, while 34 percent of Latinx adults said the same.
Henry Masur, director of the critical care medicine unit at the National Institutes of Health clinical center and a leading researcher in HIV/AIDS, says there is no evidence that mRNA COVID-19 vaccines or Johnson & Johnsons vaccine interact at all with HIV medications, including the preventive drug PrEP.
Theres no biological reason that I can at least imagine as to why that should interfere or interact with your anti-HIV drugs, Masur said. And in fact, there is no data that I know of, in addition to plausibility, that would suggest that there is any interaction.
Why Isn’t There An Ebola Vaccine
One question many are asking is why — if Ebola has been around for decades — scientists have not come up with a vaccine.
The National Institutes of Health began working on an Ebola vaccine after 9/11, when biological weapons were a big concern. But getting from test tubes to humans is expensive and complicated, especially for an exotic disease that, until now, was popping up in small numbers and contained to another continent.
So why don’t we have an Ebola vaccine now?
“The main reason is that up until the outbreak of Ebola in West Africa, it was not a very high priority,” says Dr. Myron Levine, an infectious disease specialist at the University of Maryland School of Medicine. He’s been working on vaccines — including one for Ebola — for 44 years.
“With limited resources to test vaccines, et cetera, one always has to pick and choose what are the highest priorities.”
And when stacked against everyday threats like cancer and the flu, there wasn’t a financial incentive for pharmaceutical companies to put money into Ebola research. Dr. Anthony Fauci is the head of infectious diseases at the NIH.
So the bulk of the research was left to government funding. Earlier this week, NIH director Francis Collins said we’d likely have a vaccine already if not for a decade of budget cuts.
Recommended Reading: Hiv From Dried Blood